Bringing Hidden Biases Into Light: Comments on an Observational Study on the Use of Antifibrinolytics for Pediatric Patients With Life-Threatening Hemorrhage
- PMID: 35311792
- DOI: 10.1097/CCM.0000000000005421
Bringing Hidden Biases Into Light: Comments on an Observational Study on the Use of Antifibrinolytics for Pediatric Patients With Life-Threatening Hemorrhage
Conflict of interest statement
Drs. Aita and Okuda disclosed work for hire. The remaining authors have disclosed that they do not have any potential conflicts of interest.
Comment in
-
The authors reply.Crit Care Med. 2022 Apr 1;50(4):e409-e410. doi: 10.1097/CCM.0000000000005457. Crit Care Med. 2022. PMID: 35311793 No abstract available.
Comment on
-
Use of Antifibrinolytics in Pediatric Life-Threatening Hemorrhage: A Prospective Observational Multicenter Study.Crit Care Med. 2022 Apr 1;50(4):e382-e392. doi: 10.1097/CCM.0000000000005383. Crit Care Med. 2022. PMID: 34661553
References
-
- Spinella PC, Leonard JC, Gaines BA, et al.; MAssive Transfusion epidemiology and outcomes In Children (MATIC) Investigators and BloodNet: Use of Antifibrinolytics in Pediatric Life-Threatening Hemorrhage: A Prospective Observational Multicenter Study. Crit Care Med 2022; 50:e382–e392
-
- VanderWeele TJ: Principles of confounder selection. Eur J Epidemiol 2019; 34:211–219
-
- Suissa S: Effectiveness of inhaled corticosteroids in chronic obstructive pulmonary disease: Immortal time bias in observational studies. Am J Respir Crit Care Med 2003; 168:49–53
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources